rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-23
|
pubmed:abstractText |
Arterial hypertension is a factor of major risk of cardiovascular complications which represent the first cause of death in the world. One can define it as a level of blood pressure (140/90 mmHg) beyond which the cardiovascular risk is important and requires a therapeutic action. One of the etiopathogenic assumptions selected is a disordered state of the relation pressure natriuresis wich is the major mechanism of control of long-term arterial pressure. The diagnostic means and of monitoring were the subject of consensus on the level of scientific societies what is not the case of the therapeutic strategy . In more of lifestyle change, the patients with renal diseases generally require an association of antihypertensive drugs whose the thiazide diuretics ones must have a leader place. Their association with ACE inhibitors or angiotensin receptor antagonists seem to give the best effectiveness in term of cardioprotection and nephroprotection.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0049-1101
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19102111-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19102111-Cardiovascular Diseases,
pubmed-meshheading:19102111-Clinical Trials as Topic,
pubmed-meshheading:19102111-Diabetes Complications,
pubmed-meshheading:19102111-Drug Therapy, Combination,
pubmed-meshheading:19102111-Exercise,
pubmed-meshheading:19102111-Humans,
pubmed-meshheading:19102111-Hypertension,
pubmed-meshheading:19102111-Hypolipidemic Agents,
pubmed-meshheading:19102111-Kidney,
pubmed-meshheading:19102111-Kidney Diseases,
pubmed-meshheading:19102111-Life Style,
pubmed-meshheading:19102111-Obesity,
pubmed-meshheading:19102111-Platelet Aggregation Inhibitors,
pubmed-meshheading:19102111-Renal Insufficiency,
pubmed-meshheading:19102111-Risk Factors,
pubmed-meshheading:19102111-Smoking,
pubmed-meshheading:19102111-Smoking Cessation,
pubmed-meshheading:19102111-Sodium Chloride Symporter Inhibitors,
pubmed-meshheading:19102111-Weight Loss,
pubmed-meshheading:19102111-World Health Organization
|
pubmed:year |
2008
|
pubmed:articleTitle |
[Arterial hypertension and the kidney].
|
pubmed:affiliation |
Service de Néphrologie, CHU A. le Dantec, BP 6548, Dakar, Senegal. niangabdou@yahoo.com
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|